Osteoporosis
Conference Coverage
Abaloparatide significantly reduced fractures, increased BMD in women at high fracture risk
Abaloparatide showed noninferiority against teriparatide and significant improvement against placebo for women at high or very high fracture risk...
Conference Coverage
Cut risedronate drug holiday to under 2 years in older patients
Risedronate confers less hip fracture protection than alendronate during drug holidays beyond 2 years, so a 2- to 3-year drug holiday for...
Conference Coverage
Exercise appears to improve bone structure, not density
In postmenopausal women, exercise appears to improve strength at the hip through changes in structure, not bone mineral density (BMD), whereas a...
Conference Coverage
Could the osteoporosis drug alendronate ward off diabetes?
‘This is an interesting retrospective analysis, but it should be verified with other data such as a meta-analysis from clinical trials of...
From the Journals
Bone density gains are lost following stop of denosumab in glucocorticoid-treated RA
When denosumab is discontinued, glucocorticoid-treated patients with rheumatoid arthritis need to transition to another osteoporosis therapy.
Guidelines
Menopause society issues first osteoporosis advice in 10 years
In the first update since 2010, the North American Menopause Society addresses new advances, including use of novel agents to prevent “bone...
From the Journals
Vertebral fractures still a risk with low-dose oral glucocorticoids for RA
Vertebral, not other, osteoporotic fractures were increased in current versus past users of low-dose steroids in a retrospective cohort study.
From the Journals
Osteoporosis linked to increased risk of hearing loss
Moderate to severe hearing loss was independently associated with osteoporosis, vertebral fracture in the large, longitudinal Nurses’ Health Study...
From the Journals
Any bone break increases risk for subsequent fracture in older women
Although most guidelines warn of subsequent fracture risk after hip and spine fractures, the increased risk is seen in a multitude of other bone...
Guidelines
Don’t screen for vitamin D in general population, says USPSTF
There is insufficient evidence that screening for vitamin D deficiency among the asymptomatic general population is of any benefit, concludes an...
From the Journals
COVID-19 vaccination in RMD patients: Safety data “reassuring”
Two studies show mainly mild reactions and favorable antibody responses in patients with rheumatic and musculoskeletal diseases after vaccination...